Stay updated on Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial

Sign up to get notified when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New history entries show updated Study Status and added Contacts/Locations for the trial, reflecting changes in its current operational status and contact points; an earlier version entry dated 2026-06-02 was removed.
    Difference
    0.1%
    Check dated 2026-06-19T09:29:32.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The history now includes a note that recruitment is no longer looking for participants. It also records a new revision tag v3.6.0 and removes the preceding v3.5.5 revision.
    Difference
    0.0%
    Check dated 2026-06-12T14:46:18.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The study record was updated to revision v3.5.5. New sections Contacts/Locations and Study Status were added, along with Arms and Interventions.
    Difference
    0.1%
    Check dated 2026-06-05T14:15:17.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page history now includes a new revision label 'Revision: v3.5.4' and removes the previous 'Revision: v3.5.3', updating the version history.
    Difference
    0.0%
    Check dated 2026-05-15T06:29:05.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    A new history entry on 2026-05-04 adds updates to the Study Status and Contacts/Locations sections, linked to versions 436 (2026-05-01) and 435 (2026-04-30); the 2026-04-13 entry was deleted.
    Difference
    0.1%
    Check dated 2026-05-08T09:30:54.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now shows the site software revision version as v3.5.3 instead of v3.5.2, indicating an update to the ClinicalTrials.gov interface/system rather than the underlying study record.
    Difference
    0.0%
    Check dated 2026-04-24T06:33:31.000Z thumbnail image

Stay in the know with updates to Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.